Core Viewpoint - Zhaoke Ophthalmology-B (06622) has seen a significant stock price increase, rising over 7% and nearly 35% this week, indicating strong market interest and confidence in the company's future prospects [1] Company Developments - The company has obtained a medical device registration certificate for TONO-i from the National Medical Products Administration, which will be a key part of its glaucoma medical product portfolio [1] - TONO-i is designed to provide ophthalmologists with a tool to easily, accurately, and thoroughly monitor patients' intraocular pressure, thereby improving patient adherence to glaucoma medication treatment [1] - The introduction of TONO-i into the company's pipeline underscores its commitment to dual approaches in glaucoma management, focusing on both treatment and diagnosis [1] Strategic Partnerships - In November 2022, the company entered into an exclusive distribution agreement with C&VTech, a leading company in the field of glaucoma diagnostic, treatment, and prevention medical devices [1] - The agreement grants the company exclusive rights to register, import, promote, distribute, market, and sell TONO-i in Greater China, with rights later expanded to include Thailand and Malaysia, effective from August 2024 [1]

Core Viewpoint - The company has received a medical device registration certificate for TONO-i from the National Medical Products Administration, marking a significant advancement in its glaucoma product portfolio [1] Group 1: Product Overview - TONO-i is an innovative, non-contact, portable, and lightweight tonometer designed for painless and infection-free use without anesthesia [1] - The device aims to address the low diagnosis and treatment rates for glaucoma in China, providing an essential tool for ophthalmologists to monitor intraocular pressure accurately and continuously [1] Group 2: Strategic Partnerships - In November 2022, the company entered into an exclusive distribution agreement with C&VTech, a leading company in the field of glaucoma diagnostic and treatment medical devices [1] - The agreement grants the company exclusive rights to register, import, promote, distribute, market, and sell TONO-i in Greater China, which has since been expanded to include Thailand and Malaysia, effective from August 2024 [1]